| Abstract Objective: To compare the application of nasojejunal tube enteral nutrition (JEN) and nasogastric tube enteral nutrition (GEN) in patients with diabetes complicated with hypertensive cerebral hemorrhage after surgery. Methods: In total, 82 patients with diabetes complicated with hypertensive intracerebral hemorrhage after operation were selected and divided into the observation group (JEN nutrition) and the control group (GEN nutrition) according to the random number table, with 41 patients in each group. The Glasgow Coma Scale (GCS), the National Institutes of Health Stroke Scale (NIHSS) score, hemoglobin (Hb), albumin (AIb), prealbumin (PA), CD4+, CD8+, CD4+/CD8+ levels and complications of the two groups were compared before and after treatment. Results: The GCS scores, Hb, Alb, PA, CD4+, CD4+/CD8+ levels were obviously increased in both groups after therapy, and the observation group showed a more obvious increase than the control group (P< 0.05). The NlHSS score and CD8+ level in both groups were obviously reduced after therapy, and the observation group showed a more obvious decrease than the control group (P< 0.05). Compared with the control group, the incidence of complications (such as lung infections and pressure ulcers) in the observation group was obviously reduced (P< 0.05). Conclusion Compared with GEN therapy, JEN therapy is more effective for patients with diabetes complicated with hypertensive cerebral hemorrhage, which can further improve nutritional status, improve neurological and immune functions, reduce the incidence of complications, and promote the recovery of patients. |
